Health
Moderna Gets 30,000 Patients for Final Stage of Vaccine Trial – BloombergQuint
Moderna Gets 30,000 Patients for Final Stage of Vaccine Trial
(Bloomberg) — Moderna Inc. has completed enrollment of its 30,000 participants in its final-stage Covid-19 trial, while more than 25,000 volunteers have received their second shot.
Continue Reading
